Martin Fischer was selected from an international pool of nominees for his groundbreaking research on gene regulation by ...

Cancer cells exhibit a distinct metabolism compared to normal cells, characterized by enhanced glycolysis and glutaminolysis ...

Another intriguing avenue of research involves combining PNC-27 with emerging cancer agent strategies, such as immunotherapy and gene editing. The peptide's potential to disrupt cancer cell membranes ...

Studies revealed that genetic predisposition contributes to prostate cancer development, but lifestyle choices play a crucial ...

Ginger has skin cancer, which has manifested in a kidney-shaped tumor about 5 inches in length ... You need to let your ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

Biotechnology, GlobeNewswire, Health, Product / Services Announcement | SPRING, Texas, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Io Therapeu ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations ...

Scientists at the University of Michigan Rogel Cancer Center have made a breakthrough in understanding how some prostate cancers transform into aggressive forms that are much harder to treat. The team ...

Andrew Feinberg, the Bloomberg Distinguished Professor of Biomedical Engineering at Johns Hopkins University, has been ...